Meeder Advisory Services Inc. Acquires 1,062 Shares of CME Group Inc. (NASDAQ:CME)

Key Points

• Meeder Advisory Services Inc. increased its holdings in CME Group Inc. by 19.2% during Q1 2023, owning 6,598 shares valued at approximately $1.75 million.
• Insiders sold a total of 10,400 shares of CME Group stock over the last ninety days, with Derek Sammann and Phyllis M. Lockett both significantly reducing their ownership percentages.
• CME Group reported earnings of $2.96 per share for the last quarter, beating expectations and showcasing a 10.4% revenue increase compared to the previous year.

Meeder Advisory Services Inc. boosted its position in CME Group Inc. (NASDAQ:CME - Free Report) by 19.2% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,598 shares of the financial services provider's stock after purchasing an additional 1,062 shares during the quarter. Meeder Advisory Services Inc.'s holdings in CME Group were worth $1,750,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also bought and sold shares of CME. Geode Capital Management LLC raised its position in shares of CME Group by 1.3% during the 4th quarter. Geode Capital Management LLC now owns 8,389,442 shares of the financial services provider's stock valued at $1,946,717,000 after buying an additional 104,697 shares in the last quarter. Price T Rowe Associates Inc. MD grew its holdings in shares of CME Group by 89.9% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 8,280,785 shares of the financial services provider's stock valued at $1,923,047,000 after purchasing an additional 3,921,278 shares during the last quarter. FIL Ltd grew its holdings in shares of CME Group by 1.5% during the 4th quarter. FIL Ltd now owns 4,081,391 shares of the financial services provider's stock valued at $947,821,000 after purchasing an additional 61,908 shares during the last quarter. Northern Trust Corp grew its holdings in shares of CME Group by 11.4% during the 4th quarter. Northern Trust Corp now owns 3,943,454 shares of the financial services provider's stock valued at $915,788,000 after purchasing an additional 403,920 shares during the last quarter. Finally, Janus Henderson Group PLC grew its holdings in shares of CME Group by 24.7% during the 4th quarter. Janus Henderson Group PLC now owns 3,135,753 shares of the financial services provider's stock valued at $728,260,000 after purchasing an additional 621,713 shares during the last quarter. 87.75% of the stock is currently owned by hedge funds and other institutional investors.

CME Group Trading Up 0.2%

Shares of CME traded up $0.54 during trading hours on Thursday, reaching $278.28. 1,961,429 shares of the company traded hands, compared to its average volume of 2,036,733. The company's fifty day moving average price is $276.14 and its two-hundred day moving average price is $263.55. The company has a market capitalization of $100.28 billion, a price-to-earnings ratio of 26.94, a price-to-earnings-growth ratio of 4.93 and a beta of 0.44. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. CME Group Inc. has a 12 month low of $193.25 and a 12 month high of $290.79.

CME Group (NASDAQ:CME - Get Free Report) last issued its quarterly earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.91 by $0.05. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The company had revenue of $1.69 billion during the quarter, compared to analysts' expectations of $1.68 billion. During the same period last year, the company posted $2.56 EPS. CME Group's revenue was up 10.4% on a year-over-year basis. Equities research analysts predict that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, June 25th. Investors of record on Monday, June 9th were given a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a yield of 1.8%. The ex-dividend date of this dividend was Monday, June 9th. CME Group's dividend payout ratio (DPR) is 48.40%.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on CME shares. Wall Street Zen lowered shares of CME Group from a "hold" rating to a "sell" rating in a report on Sunday, July 13th. Keefe, Bruyette & Woods increased their target price on shares of CME Group from $265.00 to $273.00 and gave the company a "market perform" rating in a report on Thursday, April 24th. Barclays set a $298.00 target price on shares of CME Group and gave the company an "equal weight" rating in a report on Thursday, July 24th. Citigroup raised their price target on shares of CME Group from $265.00 to $275.00 and gave the stock a "neutral" rating in a report on Thursday, July 3rd. Finally, Bank of America raised their price target on shares of CME Group from $200.00 to $219.00 and gave the stock an "underperform" rating in a report on Wednesday, April 2nd. Four equities research analysts have rated the stock with a sell rating, nine have given a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Hold" and an average price target of $261.93.

Insider Activity at CME Group

In related news, insider Derek Sammann sold 4,650 shares of CME Group stock in a transaction dated Monday, May 5th. The shares were sold at an average price of $280.61, for a total transaction of $1,304,836.50. Following the completion of the transaction, the insider directly owned 8,336 shares of the company's stock, valued at $2,339,164.96. This trade represents a 35.81% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Phyllis M. Lockett sold 1,060 shares of CME Group stock in a transaction dated Monday, May 19th. The stock was sold at an average price of $277.88, for a total transaction of $294,552.80. Following the completion of the transaction, the director directly owned 3,108 shares of the company's stock, valued at $863,651.04. This trade represents a 25.43% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 10,400 shares of company stock worth $2,881,130 over the last 90 days. 0.30% of the stock is currently owned by insiders.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.